We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BICK
4701
DELISTED
First Trust BICK Index Fund
BICK
$8K ﹤0.01%
327
-1
-0.3% -$26
AZRE
4702
DELISTED
Azure Power Global Limited
AZRE
$8K ﹤0.01%
3,346
+2,555
+323% +$8.69K
IDW
4703
DELISTED
IDW Media Holdings
IDW
$8K ﹤0.01%
11,213
+2,718
+32% +$2.53K
BOXD
4704
DELISTED
Boxed, Inc.
BOXD
$8K ﹤0.01%
44,586
+9,831
+28% +$4.42K
LCI
4705
DELISTED
Lannett Company, Inc.
LCI
$8K ﹤0.01%
4,348
+834
+24% +$1.84K
CFMS
4706
DELISTED
Conformis, Inc. Common Stock
CFMS
$8K ﹤0.01%
5,273
+3,305
+168% +$7.11K
CFRX
4707
DELISTED
ContraFect Corporation
CFRX
$8K ﹤0.01%
4,156
+4,155
+415,500% +$19.5K
ACNT icon
4708
Ascent Industries
ACNT
$133M
$7K ﹤0.01%
762
-275
-27% -$2.77K
AEI icon
4709
Alset
AEI
$43.6M
$7K ﹤0.01%
4,200
+1,858
+79% +$4.1K
AGM.A icon
4710
Federal Agricultural Mortgage Class A
AGM.A
$1.79B
$7K ﹤0.01%
65
-85
-57% -$9.53K
AMRX icon
4711
Amneal Pharmaceuticals
AMRX
$6.15B
$7K ﹤0.01%
5,076
-3,363
-40% -$6.7K
AOR icon
4712
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
$7K ﹤0.01%
131
-17
-11% -$836
APRE icon
4713
Aprea Therapeutics
APRE
$8.31M
$7K ﹤0.01%
1,477
-902
-38% -$6.66K
ASTI icon
4714
Ascent Solar Technologies
ASTI
$32.7M
$7K ﹤0.01%
+1
New +$16.9K
BBGI icon
4715
Beasley Broadcasting Group
BBGI
$39.3M
$7K ﹤0.01%
451
+88
+24% +$1.86K
ALOY
4716
REalloys Inc
ALOY
$884M
$7K ﹤0.01%
2,305
+293
+15% +$806
BOXL icon
4717
Boxlight
BOXL
$4.54M
$7K ﹤0.01%
13
-16
-55% -$10.3K
BRCC icon
4718
BRC Inc
BRCC
$215M
$7K ﹤0.01%
1,537
+788
+105% +$4.95K
BRID icon
4719
Bridgford Foods
BRID
$57.4M
$7K ﹤0.01%
531
-1,310
-71% -$16.9K
BW icon
4720
Babcock & Wilcox
BW
$1.39B
$7K ﹤0.01%
1,206
-2,508
-68% -$15.5K
CBUS icon
4721
Cibus
CBUS
$145M
$7K ﹤0.01%
404
+2
+0.5% +$33
CIFR icon
4722
Cipher Digital
CIFR
$6.9B
$7K ﹤0.01%
3,126
-12,101
-79% -$18.6K
CISO
4723
CISO Global
CISO
$12.2M
$7K ﹤0.01%
1,361
+1,111
+444% +$18.1K
CLRB icon
4724
Cellectar Biosciences
CLRB
$20.8M
$7K ﹤0.01%
152
-108
-42% -$5.26K
ZSQR
4725
Z Squared Inc
ZSQR
$205M
$7K ﹤0.01%
247
+233
+1,664% +$7.43K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.